Skip To Main Content

Inspiration and Innovation

Get inspired and stay on the cutting edge of innovation with these resources.

Sort by

Filters

Reset
  • Therapeutical Areas
  • Type of Content

Management of Patients With Very High Cardiovascular Risk Eligible for PCSK9 Inhibitor Treatment: 1-year Outcomes of The PERI-DYS Study

Acute LDL-C Reduction Post ACS: Strike Early and Strike Strong: From Evidence to Clinical Practice

Management of ASMD - Expert opinion: Professor Moeen Al Sayed

Professor Moeen gives a detailed explanation on how Olipudase Alfa acts in the body once administered.

Differential diagnostics for ASMD in patients suspected to have GD

Impact of symptoms and risk of ASMD on patients and caregivers

Consensus Guidelines for the Clinical Management of ASMD

Inside Diabetes: ATTD Edition | Type 1 Diabetes

DIAGNOSING FABRY DISEASE IN CLINICAL PRACTICE

ROLE OF ECG IN DIFFERENTIAL DIAGNOSIS OF ANDERSON–FABRY DISEASE WITH HCM

BIOCHEMICAL DIAGNOSTIC STRATEGY IN FEMALES SUSPECTED OF FABRY DISEASE

Management of ASMD - Expert opinion: Professor Fatma Al- Jasmi

Professor Fatma explains the effect of Olipudase Alfa on the symptoms presented in patients with ASMD.

Pompe Care Podcast Series

Welcome to Pompe Care podcast series, today’s episodes we speak to Dr. Amal Al Teneiji, Metabolic Genetics Consultant at Sheikh Khalifa Medical City Abu Dhabi, about Pompe disease. We talk about typical diagnosis of patient journey, challenges facing, new diagnostic technologies, effective ways to support patients and families and social stigma.